These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 3315584

  • 1. Reperfusion in acute myocardial infarction. A multicentre randomised trial of early intracoronary streptokinase and intravenous anisoylated plasminogen streptokinase activator complex in the United States.
    Anderson JL.
    Drugs; 1987; 33 Suppl 3():154-62. PubMed ID: 3315584
    [Abstract] [Full Text] [Related]

  • 2. Multicenter reperfusion trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: controlled comparison with intracoronary streptokinase.
    Anderson JL, Rothbard RL, Hackworthy RA, Sorensen SG, Fitzpatrick PG, Dahl CF, Hagan AD, Browne KF, Symkoviak GP, Menlove RL.
    J Am Coll Cardiol; 1988 Jun; 11(6):1153-63. PubMed ID: 3284943
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comparison of intravenous anisoylated plasminogen streptokinase activator complex and intracoronary streptokinase in acute myocardial infarction.
    Bonnier HJ, Visser RF, Klomps HC, Hoffmann HJ.
    Am J Cardiol; 1988 Jul 01; 62(1):25-30. PubMed ID: 3289357
    [Abstract] [Full Text] [Related]

  • 5. Intracoronary streptokinase versus intravenous anisoylated plasminogen streptokinase activator complex in the treatment of acute myocardial infarction.
    Kaspar L, Karnik R, Sehnal E, Zajicek P, Ziegler B, Slany J.
    Drugs; 1987 Jul 01; 33 Suppl 3():179-82. PubMed ID: 3315588
    [Abstract] [Full Text] [Related]

  • 6. Intravenous anisoylated plasminogen streptokinase activator complex versus intravenous streptokinase in evolving myocardial infarction. Preliminary data from a randomised multicentre study.
    Brochier ML, Quilliet L, Kulbertus H, Materne P, Letac B, Cribier A, Monassier JP, Sacrez A, Favier JP.
    Drugs; 1987 Jul 01; 33 Suppl 3():140-5. PubMed ID: 3315581
    [Abstract] [Full Text] [Related]

  • 7. An interim report of the efficacy and safety of anisoylated plasminogen streptokinase activator complex (APSAC).
    Johnson ES, Cregeen RJ.
    Drugs; 1987 Jul 01; 33 Suppl 3():298-311. PubMed ID: 3315612
    [Abstract] [Full Text] [Related]

  • 8. Electrocardiographic and enzymatic infarct size in a randomised study of intracoronary streptokinase and intravenous anisoylated plasminogen streptokinase activator complex in acute myocardial infarction.
    Hackworthy RA, Sorensen SG, Menlove RL, Anderson JL.
    Drugs; 1987 Jul 01; 33 Suppl 3():198-208. PubMed ID: 3315592
    [Abstract] [Full Text] [Related]

  • 9. Summary of early clinical experience with anisoylated plasminogen streptokinase activator complex in the treatment of acute myocardial infarction.
    Jackson D.
    Drugs; 1987 Jul 01; 33 Suppl 3():104-11. PubMed ID: 3315574
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Dose-ranging studies of anisoylated plasminogen streptokinase activator complex. Studies in healthy volunteers and in patients with acute myocardial infarction.
    Marder VJ, Rothbard RL, Fitzpatrick PG, Francis CW, Norry EC.
    Drugs; 1987 Jul 01; 33 Suppl 3():124-32. PubMed ID: 3315577
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparative tolerance and complications in a multicentre trial of intracoronary streptokinase and intravenous anisoylated plasminogen streptokinase activator complex in acute myocardial infarction.
    Rothbard RL.
    Drugs; 1987 Jul 01; 33 Suppl 3():276-8. PubMed ID: 3315606
    [Abstract] [Full Text] [Related]

  • 16. Acute coronary occlusion and reperfusion. Reliability of angiographic classification and grading.
    Sorensen SG, Hackworthy RA, Fitzpatrick PG, Barry WH, Menlove RL, Anderson JL.
    Drugs; 1987 Jul 01; 33 Suppl 3():163-8. PubMed ID: 3315585
    [Abstract] [Full Text] [Related]

  • 17. Development and evaluation of anisoylated plasminogen streptokinase activator complex (APSAC) as a second generation thrombolytic agent.
    Anderson JL.
    J Am Coll Cardiol; 1987 Nov 01; 10(5 Suppl B):22B-27B. PubMed ID: 3312369
    [Abstract] [Full Text] [Related]

  • 18. Anisoylated plasminogen streptokinase activator complex versus streptokinase in acute myocardial infarction. Preliminary results of a randomised study.
    Monnier P, Sigwart U, Vincent A, Bachmann F, Goy JJ, Schaller MD, Kaufmann U, Badan M, Grbic M, Perret C.
    Drugs; 1987 Nov 01; 33 Suppl 3():175-8. PubMed ID: 3315587
    [Abstract] [Full Text] [Related]

  • 19. Analysis of coagulation and fibrinolysis after intravenous anisoylated plasminogen streptokinase activator complex or heparin in patients with acute myocardial infarction. A Belgian multicentre study.
    Renkin J, Beys CC, Lavenne-Pardonge E, Pintens H, Col J.
    Drugs; 1987 Nov 01; 33 Suppl 3():253-60. PubMed ID: 3315603
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of 2 intravenous thrombolytic agents (anisoylated plasminogen streptokinase activator complex versus streptokinase) in patients with acute myocardial infarction.
    Seabra-Gomes R, Aniceto Silva J, Aleixo A, Real T, Freire I, Torres I, Freitas R, Crespo F.
    Drugs; 1987 Nov 01; 33 Suppl 3():169-74. PubMed ID: 3315586
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.